Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | CTSD | P07339 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | ALPL | P05186 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL397874 | 1.00 | ALDH1A1 (0.58) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL4252583 | 0.82 | GPR35 (0.56) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL4252579 | 0.82 | GPR35 (0.56) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL28958222 | 0.82 | ALDH1A1 (0.56) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL6142099 | 0.82 | ALDH1A1 (0.56) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL1206488 | 0.82 | CTSD (0.58) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL30727560 | 0.81 | TSHR (0.67) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL29696138 | 0.81 | TSHR (0.67) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL78205 | 0.81 | TSHR (0.67) | ALDH1A1CTSDTDP1ALPLGAA | |
| SCHEMBL4078013 | 0.80 | ALDH1A1 (0.64) | ALDH1A1CTSDTDP1ALPLKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403791-B | Universal method for preparing high molecular nano particles | 山东大学 | 2025-02-25 | — | — | CN | claimed |
| US-6743598-B2 | SIMULTANEOUSLY ASSESSING MICROBIAL PHOSPHOGLUCOSE ISOMERASE, KETOL-ISOMERASE AND GLUCOSAMINE-6-PHOSPHATE ACETYLTRANSFERASE ACTIVITIES | MYCOLOGICS, INC. | 2004-06-01 | — | — | US | claimed |
| US-20030194758-A1 | Methods for the identification of fungal glucose utilization inhibitors and antifungal agents | MYCOLOGICS, INC. | 2003-10-16 | — | — | US | claimed |
| US-20030087877-A1 | Modification of biopolymers for improved drug delivery | CENZYME CORPORATION | 2003-05-08 | — | — | US | claimed |
| EP-1263472-A2 | MODIFICATION OF BIOPOLYMERS FOR IMPROVED DRUG DELIVERY | GENZYME CORPORATION (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001060412-A2 | MODIFICATION OF BIOPOLYMERS FOR IMPROVED DRUG DELIVERY | GENZYME CORPORATION (US) | 2001-08-23 | — | — | WO | claimed |
| CN-115403791-B | Universal method for preparing high molecular nano particles | 山东大学 | 2025-02-25 | — | — | CN | disclosed |
| US-11980669-B2 | Capped and uncapped antibody cysteines, and their use in antibody-drug conjugation | PFIZER, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| CN-117607133-A | Aromatic amine N-acetyltransferase activity detection kit and application thereof | 南方海洋科学与工程广东省实验室(广州) | 2024-02-27 | — | — | CN | disclosed |
| CN-117607133-A | Aromatic amine N-acetyltransferase activity detection kit and application thereof | 南方海洋科学与工程广东省实验室(广州) | 2024-02-27 | — | — | CN | disclosed |
| CN-107849121-B | Blocked and unblocked antibody cysteines and their use in antibody-drug conjugation | 辉瑞公司 | 2021-11-09 | — | — | CN | disclosed |
| EP-3808768-A1 | CAPPED AND UNCAPPED ANTIBODY CYSTEINES, AND THEIR USE IN ANTIBODY-DRUG CONJUGATION | Pfizer Inc. (US) | 2021-04-21 | — | — | EP | disclosed |
| EP-3334760-B1 | CAPPED AND UNCAPPED ANTIBODY CYSTEINES, AND THEIR USE IN ANTIBODY-DRUG CONJUGATION | PFIZER (US) | 2021-03-10 | — | — | EP | disclosed |
| EP-0083975-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-19 | — | — | EP | disclosed |
| US-4695311-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-09-22 | — | — | US | disclosed |
| US-4615877-A | Method of determining the oxidizing activity of a biological liquid, and a corresponding reagent | SAVAPA S.R.L. (IT) | 1986-10-07 | — | — | US | disclosed |
| US-4606755-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-08-19 | — | — | US | disclosed |
| US-4511392-A | N--/PYRIMIDIN-2-YLAMINOCARBENYL/-HETERO-SUBSTITUETED BENZENSESULFO | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-16 | — | — | US | disclosed |
| EP-0083975-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-07-20 | — | — | EP | disclosed |
| EP-0034883-A1 | 2-Nitro-5-(substituted-phenoxy) benzoyl derivatives as herbicides | RHONE-POULENC INC. (US) | 1981-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11980669-B2 | Capped and uncapped antibody cysteines, and their use in antibody-drug conjugation | GCLC, LANCL1, CTH | ALDH1A1 459/4885CTSD 2390/4885TDP1 4390/4885 |
| US-20030087877-A1 | Modification of biopolymers for improved drug delivery | PTMS, PDIA6, SDCBP | ALDH1A1 1420/4885CTSD 1899/4885TDP1 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.